Cancer: Still a contraindication for allergen immunotherapy? Specific immunotherapy and cancer

被引：3
|
作者：
El-Qutob, David [1 ]
Letran, Antonio [2 ]
Matheu, Victor [3 ]
Fernandez-Caldas, Enrique [4 ,5 ]
机构：
[1] Univ Hosp La Plana, Allergy Unit, Vila Real, Spain
[2] Hosp HLA Jerez Puerta Sur, Allergy Unit, Cadiz, Spain
[3] Univ Hosp Canarias, Serv Allergol, Tenerife, Spain
[4] Inmunotek SL, Madrid, Spain
[5] Univ S Florida, Coll Med, Tampa, FL 33620 USA
来源：
WORLD ALLERGY ORGANIZATION JOURNAL | 2021年 / 14卷 / 10期
关键词：
Cancer; Neoplasm; Specific immunotherapy; Allergen; Contraindication; GRASS-POLLEN IMMUNOTHERAPY; REGULATORY T-CELLS; MALIGNANCY; EXPERIENCE; MECHANISMS; INDUCTION; DISEASES; IL-10; IGG4; IGE;
D O I：
10.1016/j.waojou.2021.100597
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Allergen immunotherapy (AIT) is currently more than 100 years old. It is considered an evidencebased efficacious immune therapeutical treatment. It is at this time the only causative treatment for allergic respiratory and venom allergic diseases. Though clinical indications for AIT are well established, clinical contraindications to AIT differ among several guidelines. Regarding malignant neoplasia, traditionally, it has been considered as a relative or absolute contraindication with the concern that AIT might stimulate tumour growth even though pathogenic impact of AIT in cancer is not well understood. Furthermore, this contraindication is often based on observational case series, or case reports, with little real evidence-based data. Therefore, should cancer still be contemplated as an absolute contraindication for AIT? Keywords: Cancer, Neoplasm, Specific immunotherapy, Allergen, Contraindication
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Mechanisms of allergen-specific immunotherapy
    Akdis, CA
    Blaser, K
    ALLERGY, 2000, 55 (06) : 522 - 530
  • [22] Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
    Marth K.
    Focke-Tejkl M.
    Lupinek C.
    Valenta R.
    Niederberger V.
    Current Treatment Options in Allergy, 2014, 1 (1) : 91 - 106
  • [23] Mechanisms of allergen-specific immunotherapy and allergen tolerance
    Kucuksezer, Umut C.
    Ozdemir, Cevdet
    Cevhertas, Lacin
    Ogulur, Ismail
    Akdis, Mubeccel
    Akdis, Cezmi A.
    ALLERGOLOGY INTERNATIONAL, 2020, 69 (04) : 549 - 560
  • [24] Allergen specific immunotherapy in elderly people
    Bozek, Andrzej
    ALERGIA ASTMA IMMUNOLOGIA, 2015, 20 (03): : 167 - 169
  • [25] Mechanisms of allergen-specific immunotherapy
    Akdis, Muebeccel
    Akdis, Cezmi A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (04) : 780 - 789
  • [26] A Review of Allergy and Allergen Specific Immunotherapy
    Bidad, Katayoon
    Nicknam, Mohammad Hossein
    Farid, Reza
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2011, 10 (01) : 1 - 9
  • [27] Immunologic characterization of 3 murine regimens of allergen-specific immunotherapy
    Fox, Ellen Mueller
    Torrero, Marina N.
    Evans, Holly
    Mitre, Edward
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (05) : 1341 - U384
  • [28] Scientific Foundations of Allergen - Specific Immunotherapy for Allergic Disease
    Soyka, Michael B.
    van de Veen, Willem
    Holzmann, David
    Akdis, Muebeccel
    Akdis, Cezmi A.
    CHEST, 2014, 146 (05) : 1347 - 1357
  • [29] Allergen-specific immunotherapy: Update on immunological mechanisms
    Alvaro, M.
    Sancha, J.
    Larramona, H.
    Lucas, J. M.
    Mesa, M.
    Tabar, A. I.
    Martinez-Canavate, A.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2013, 41 (04) : 265 - 272
  • [30] Malignancy and Specific Allergen Immunotherapy: The Results of a Case Series
    Woehrl, Stefan
    Kinaciyan, Tamar
    Jalili, Ahmad
    Stingl, Georg
    Moritz, Katharina B.
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2011, 156 (03) : 313 - 319
12345